Nanoform
Finland - HelsinkiBiotechnology
Focus: Nanoform is a Finland-based biotech company specializing in nanoparticle technology platforms to improve drug delivery and bioavailability of pharmaceutical compounds. The company operates as a public entity focused on enabling partners' drug development rather than building an internal pipeline.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Nanoform
AI assessmentNot HiringNo open roles listed right now. Follow Nanoform to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Nanoformed Piroxicam IR Tablet
PainClinical Trials (1)
NCT05104931PK Evaluation of a Nanoformed Oral IR Piroxicam Tablet in Healthy Subjects
Phase 1Help build intelligence for Nanoform
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.